MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity.
Huijbers MG, Vergoossen DL, Fillié-Grijpma YE, van Es IE, Koning MT, Slot LM, Veelken H, Plomp JJ, van der Maarel SM, Verschuuren JJ.
Huijbers MG, et al. Among authors: van es ie.
Neurol Neuroimmunol Neuroinflamm. 2019 Feb 21;6(3):e547. doi: 10.1212/NXI.0000000000000547. eCollection 2019 May.
Neurol Neuroimmunol Neuroinflamm. 2019.
PMID: 30882021
Free PMC article.